- Home
- RNAZ vs TRUG Comparison
RNAZ vs TRUG Comparison
Compare RNAZ & TRUG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNAZ
- TRUG
- Stock Information
- Founded
- RNAZ 2016
- TRUG 1983
- Country
- RNAZ United States
- TRUG United States
- Employees
- RNAZ N/A
- TRUG N/A
- Industry
- RNAZ Biotechnology: Pharmaceutical Preparations
- TRUG
- Sector
- RNAZ Health Care
- TRUG
- Exchange
- RNAZ Nasdaq
- TRUG NYSE
- Market Cap
- RNAZ 8.3M
- TRUG 8.0M
- IPO Year
- RNAZ 2021
- TRUG N/A
- Fundamental
- Price
- RNAZ $0.34
- TRUG $0.47
- Analyst Decision
- RNAZ Strong Buy
- TRUG
- Analyst Count
- RNAZ 1
- TRUG 0
- Target Price
- RNAZ $3.00
- TRUG N/A
- AVG Volume (30 Days)
- RNAZ 606.0K
- TRUG 221.4K
- Earning Date
- RNAZ 11-26-2024
- TRUG 11-22-2024
- Dividend Yield
- RNAZ N/A
- TRUG N/A
- EPS Growth
- RNAZ N/A
- TRUG N/A
- EPS
- RNAZ N/A
- TRUG N/A
- Revenue
- RNAZ N/A
- TRUG $19,112,071.00
- Revenue This Year
- RNAZ N/A
- TRUG N/A
- Revenue Next Year
- RNAZ $100.00
- TRUG N/A
- P/E Ratio
- RNAZ N/A
- TRUG N/A
- Revenue Growth
- RNAZ N/A
- TRUG N/A
- 52 Week Low
- RNAZ $0.22
- TRUG $0.40
- 52 Week High
- RNAZ $18.68
- TRUG $11.82
- Technical
- Relative Strength Index (RSI)
- RNAZ 33.05
- TRUG 21.09
- Support Level
- RNAZ $0.31
- TRUG $0.40
- Resistance Level
- RNAZ $0.49
- TRUG $0.62
- Average True Range (ATR)
- RNAZ 0.05
- TRUG 0.09
- MACD
- RNAZ -0.02
- TRUG -0.01
- Stochastic Oscillator
- RNAZ 12.67
- TRUG 10.38
About RNAZ TransCode Therapeutics Inc.
TransCode Therapeutics Inc is a clinical-stage oncology company focused on treating metastatic disease. It is committed to defeating cancer through the intelligent design and effective delivery of RNA therapeutics based on its proprietary TTX nanoparticle platform. The company's lead therapeutic candidate, TTX-MC138, is focused on treating metastatic tumors which overexpress microRNA-10b, a unique, well-documented biomarker of metastasis. In addition, TransCode is developing a portfolio of first-in-class RNA therapeutic candidates designed to overcome the challenges of RNA delivery and thus unlock therapeutic access to a variety of novel genetic targets that could be relevant to treating a variety of cancers.
About TRUG TRUGOLF HOLDINGS INC
TruGolf Holdings Inc is a indoor golf gaming solutions company. It has built video games ("Links"), innovative hardware solutions, and an all-new e-sports platform to connect golfers around the world with E6 CONNECT.